{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:24:57Z","timestamp":1761128697236},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2008,8,22]],"date-time":"2008-08-22T00:00:00Z","timestamp":1219363200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1007\/s00296-008-0687-4","type":"journal-article","created":{"date-parts":[[2008,8,21]],"date-time":"2008-08-21T15:07:07Z","timestamp":1219331227000},"page":"1223-1228","source":"Crossref","is-referenced-by-count":7,"title":["Hyperhomocysteinemia in ankylosing spondylitis: prevalence and association with clinical variables"],"prefix":"10.1007","volume":"28","author":[{"given":"Laura","family":"Gonzalez-Lopez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia D.","family":"Sanchez-Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika A. G.","family":"Aguilar-Chavez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adolfo R.","family":"Cota-Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria A.","family":"Lopez-Olivo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto I.","family":"Villa-Manzano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Ortega-Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genadia L.","family":"Espinoza-Maga\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendoline","family":"Rojo-Contreras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernesto G.","family":"Cardona-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge I.","family":"Gamez-Nava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,8,22]]},"reference":[{"key":"687_CR1","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1001\/jama.1995.03530130055028","volume":"274","author":"CJ Boushey","year":"1995","unstructured":"Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. JAMA 274:1049\u20131057. doi: 10.1001\/jama.274.13.1049","journal-title":"JAMA"},{"key":"687_CR2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.semarthrit.2004.07.010","volume":"34","author":"M Peters","year":"2004","unstructured":"Peters M, van der Horst-Bruinsma I, Dijkmans B, Nurmohamed M (2004) Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum 34:585\u2013592. doi: 10.1016\/j.semarthrit.2004.07.010","journal-title":"Semin Arthritis Rheum"},{"issue":"Suppl 28","key":"687_CR3","first-page":"S16","volume":"20","author":"J Braun","year":"2002","unstructured":"Braun J, Pincus T (2002) Mortality, course of disease and prognosis of patients with ankylosing spondylitis. Clin Exp Rheumatol 20(Suppl 28):S16\u2013S22","journal-title":"Clin Exp Rheumatol"},{"key":"687_CR4","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s10067-006-0396-x","volume":"26","author":"JC Wei","year":"2007","unstructured":"Wei JC, Jan MS, Yu CT, Huang YC, Yang CC, Tsou HK et al (2007) Plasma homocysteine status in patients with ankylosing spondylitis. Clin Rheumatol 26:739\u2013742. doi: 10.1007\/s10067-006-0396-x","journal-title":"Clin Rheumatol"},{"key":"687_CR5","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1007\/s10067-006-0380-5","volume":"26","author":"D Malesci","year":"2007","unstructured":"Malesci D, Niglio A, Mennillo GA, La Montagna G (2007) High prevalence of metabolic syndrome in patients with ankylosing spondylitis. Clin Rheumatol 26:710\u2013714. doi: 10.1007\/s10067-006-0380-5","journal-title":"Clin Rheumatol"},{"key":"687_CR6","first-page":"111","volume":"44","author":"XY Xu","year":"2005","unstructured":"Xu XY, Zhou WH, Xiao CS, Li XF, Wang LY (2005) A clinical study of hyperhomocysteinemia in rheumatological diseases. Zhonghua Nei Ke Za Zhi 44:111\u2013114","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"687_CR7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Linden van der","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361\u2013368. doi: 10.1002\/art.1780270401","journal-title":"Arthritis Rheum"},{"key":"687_CR8","first-page":"2286","volume":"21","author":"S Garrett","year":"1994","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286\u20132291","journal-title":"J Rheumatol"},{"key":"687_CR9","first-page":"2281","volume":"21","author":"A Calin","year":"1994","unstructured":"Calin A, Garrett S, Whitelock H, Kennedy LG, O\u2019Hea J, Mallorie P et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281\u20132285","journal-title":"J Rheumatol"},{"key":"687_CR10","first-page":"946","volume":"17","author":"LH Daltroy","year":"1990","unstructured":"Daltroy LH, Larson MG, Roberts NW, Liang MH (1990) A modification of the Health Assessment Questionnaire for the spondyloarthropathies. J Rheumatol 17:946\u2013950","journal-title":"J Rheumatol"},{"key":"687_CR11","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/clinchem\/41.7.991","volume":"41","author":"MT Shipchandler","year":"1995","unstructured":"Shipchandler MT, Moore EG (1995) Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx analyzer. Clin Chem 41:991\u2013994","journal-title":"Clin Chem"},{"key":"687_CR12","first-page":"2167","volume":"33","author":"C Han","year":"2006","unstructured":"Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala M (2006) Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 33:2167\u20132172","journal-title":"J Rheumatol"},{"key":"687_CR13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/03009740510026922","volume":"35","author":"MA Lopez-Olivo","year":"2006","unstructured":"Lopez-Olivo MA, Gonzalez-Lopez L, Garcia-Gonzalez A, Villa-Manzano AI, Cota-Sanchez AR, Salazar-Paramo M et al (2006) Factors associated with hyperhomocysteinaemia in Mexican patients with rheumatoid arthritis. Scand J Rheumatol 35:112\u2013116. doi: 10.1080\/03009740510026922","journal-title":"Scand J Rheumatol"},{"key":"687_CR14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1123\/ijsnem.16.4.341","volume":"16","author":"LM Joubert","year":"2006","unstructured":"Joubert LM, Manore MM (2006) Exercise, nutrition, and homocysteine. Int J Sport Nutr Exerc Metab 16:341\u2013361","journal-title":"Int J Sport Nutr Exerc Metab"},{"key":"687_CR15","first-page":"875","volume":"29","author":"S Wallberg-Jonsson","year":"2002","unstructured":"Wallberg-Jonsson S, Cvetkovic JT, Sundqvist KG, Lefvert AK, Rantapaa-Dahlqvist S (2002) Activation of the immune system and inflammatory activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis. J Rheumatol 29:875\u2013882","journal-title":"J Rheumatol"},{"key":"687_CR16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1515\/CCLM.2007.012","volume":"45","author":"K Schroecksnadel","year":"2007","unstructured":"Schroecksnadel K, Frick B, Fiegl M, Winkler C, Denz HA, Fuchs D (2007) Hyperhomocysteinaemia and immune activation in patients with cancer. Clin Chem Lab Med 45:47\u201353. doi: 10.1515\/CCLM.2007.012","journal-title":"Clin Chem Lab Med"},{"key":"687_CR17","first-page":"1615","volume":"29","author":"OK Jensen","year":"2002","unstructured":"Jensen OK, Rassmussen C, Mollerup F, Christensen PB, Hansen H, Ekelub S et al (2002) Hyperhomocysteinemia in rheumatoid arthritis: influence of methotrexate treatment and folic acid supplementation. J Rheumatol 29:1615\u20131618","journal-title":"J Rheumatol"},{"key":"687_CR18","first-page":"2374","volume":"31","author":"N Hornung","year":"2004","unstructured":"Hornung N, Ellingsen T, Stengaard-Pedersen K, Poulsen JH (2004) Folate, homocysteine, and cobalamin status in patients with rheumatoid arthritis treated with methotrexate, and the effect of low dose folic acid supplement. J Rheumatol 31:2374\u20132381","journal-title":"J Rheumatol"},{"key":"687_CR19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/ard.58.2.79","volume":"58","author":"CJ Haagsma","year":"1999","unstructured":"Haagsma CJ, Blom HJ, van Riel PL, van\u2019t Hof MA, Giesendorf BA, Van Oppenraaij-Emmerzaal D et al (1999) Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheumatoid arthritis. Ann Rheum Dis 58:79\u201384","journal-title":"Ann Rheum Dis"},{"key":"687_CR20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/ard.2003.019828","volume":"64","author":"M Hoekstra","year":"2005","unstructured":"Hoekstra M, Haagsma CJ, Doelman CJ, van de Laar MA (2005) Intermittent rises in plasma homocysteine in patients with rheumatoid arthritis treated with higher dose methotrexate. Ann Rheum Dis 64:141\u2013143. doi: 10.1136\/ard.2003.019828","journal-title":"Ann Rheum Dis"},{"key":"687_CR21","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1046\/j.1432-1327.2001.02278.x","volume":"268","author":"M Medina","year":"2001","unstructured":"Medina M, Urdiales JL, Amores-Sanchez MI (2001) Roles of homocysteine in cell metabolism: old and new functions. Eur J Biochem 268:3871\u20133882. doi: 10.1046\/j.1432-1327.2001.02278.x","journal-title":"Eur J Biochem"},{"key":"687_CR22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/35025203","volume":"407","author":"AJ Lusis","year":"2000","unstructured":"Lusis AJ (2000) Atherosclerosis. Nature 407:233\u2013241. doi: 10.1038\/35025203","journal-title":"Nature"},{"key":"687_CR23","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1161\/01.ATV.19.5.1263","volume":"19","author":"S Voutilainen","year":"1999","unstructured":"Voutilainen S, Morrow JD, Roberts LJ 2nd, Alfthan G, Alho H, Nyyssonen K, Salonen JT (1999) Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arterioscler Thromb Vasc Biol 19:1263\u20131266","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"687_CR24","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/01.RES.84.4.409","volume":"84","author":"NP Dudman","year":"1999","unstructured":"Dudman NP, Temple SE, Guo XW, Fu W, Perry MA (1999) Homocysteine enhances neutrophil-endothelial interactions in both cultured human cells and rats In vivo. Circ Res 84:409\u2013416","journal-title":"Circ Res"},{"key":"687_CR25","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/hrt.82.4.448","volume":"82","author":"PH Whincup","year":"1999","unstructured":"Whincup PH, Refsum H, Perry IJ, Morris R, Walker M, Lennon L, Thomson A, Ueland PM, Ebrahim SB (1999) Serum total homocysteine and coronary heart disease: prospective study in middle aged men. Heart 82:448\u2013454","journal-title":"Heart"},{"key":"687_CR26","doi-asserted-by":"crossref","first-page":"363","DOI":"10.7326\/0003-4819-131-5-199909070-00008","volume":"131","author":"JW Eikelboom","year":"1999","unstructured":"Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S (1999) Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 131:363\u2013375","journal-title":"Ann Intern Med"},{"key":"687_CR27","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/bmj.325.7374.1202","volume":"325","author":"DS Wald","year":"2002","unstructured":"Wald DS, Law M, Morris JK (2002) Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325:1202. doi: 10.1136\/bmj.325.7374.1202","journal-title":"BMJ"},{"key":"687_CR28","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1001\/archinte.159.10.1077","volume":"159","author":"AG Bostom","year":"1999","unstructured":"Bostom AG, Silbershatz H, Rosenberg IH, Selhub J, D\u2019Agostino RB, Wolf PA, Jacques PF, Wilson PW (1999) Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med 159:1077\u20131080. doi: 10.1001\/archinte.159.10.1077","journal-title":"Arch Intern Med"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-008-0687-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-008-0687-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-008-0687-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T21:26:09Z","timestamp":1588886769000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-008-0687-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,22]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["687"],"URL":"https:\/\/doi.org\/10.1007\/s00296-008-0687-4","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,22]]}}}